通过循环的髓状细胞进行的运输驱动了在炎症的突中脂肪体的积累
Joke Deprez1,2,3, Rein Verbeke1,2, Sofie Meulewaeter1,2
1Laboratory of General Biochemistry and Physical Pharmacy, Ghent Research Group on Nanomedicine, Ghent University, Ghent, Belgium.
Nature nanotechnology
|July 10, 2023
概括
髓状细胞,而不仅仅是组织间隙,显著地将脂质体运送到炎症关节. 这一发现挑战了作为炎症性疾病中主要药物输送途径的增强透和保留效应.
科学领域:
- 纳米医学是一种纳米医学.
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 脂质体被认为可以向炎症组织输送药物.
- 增强透和保留 (EPR) 效应是通过内皮间隙在炎症关节中的脂质体积累的假定机制.
- 循环髓状细胞在脂质体运输中的作用在很大程度上是未被探索的.
研究的目的:
- 为了研究髓质细胞对炎症组织中的脂质体输送的贡献.
- 挑战人们对在炎症条件下脂质体积累的普遍理解.
- 探索PEGylated脂质体和髓状细胞之间的相互作用.
主要方法:
- 利用一个原诱导的关节炎小鼠模型.
- 研究了炎症关节中的脂质体积累.
- 评估了髓质细胞枯竭对脂质体积累的影响.
- 研究了PEGylation对髓状细胞脂质体吸收的影响.
主要成果:
- 骨髓状细胞被证明可以将脂质体运送到炎症部位.
- 循环髓状细胞的枯竭使脂质细胞的积累减少了50-60%.
- 与预期相反,PEGylated脂质体的长血液循环时间增加了髓状细胞的吸收.
结论:
- 骨髓细胞介导的运输占炎症区域脂质体积累的半数以上.
- 增强的透和保留效应可能不是突脂肪体积累的唯一或主要机制.
- 这项研究突出了在炎症性疾病中输送脂质体的替代途径,强调了髓状细胞的作用.
相关概念视频
T Cell Types and Functions
1.1K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.1K
Inflammation
53.9K
Overview
53.9K
Drug Distribution: Tissue Binding
2.7K
Upon entering the systemic circulation, drugs can distribute into the interstitial and intracellular fluid of various tissue cells. This distribution is facilitated by the binding of drugs to different cellular components within tissues, which may lead to drug accumulation in specific areas. Drugs bound to tissue components serve as reservoirs that release free drugs back into the system, prolonging the drug's overall action. However, this accumulation can also result in local toxicity.
For...
For...
2.7K
Inflammatory Response I: Vascular and Cellular
11.4K
The inflammatory response is the body's defense against infection, injury, or irritation from bacteria, trauma, toxins, or heat. Inflammation helps locate and destroy pathogens and remove damaged tissue elements to heal the body. During this initial phase, fluid, blood products, and nutrients migrate to the injured area, resulting in redness, heat, swelling, ache, and loss of function. Moreover, signs of systemic inflammation include fever, increased WBC count, malaise, anorexia, nausea,...
11.4K
Lymphatic Vessels and Lymph Transport
3.7K
Lymphatic vessels, known as lymphatics, are crucial in transporting lymph from peripheral tissues to our venous system. This process begins with lymph entering through tiny capillaries that branch through tissues. These capillaries have unique features such as larger diameters, thinner walls, and a distinctive one-way valve system formed by overlapping endothelial cells.
This one-way system allows fluids, solutes, and even pathogens to enter but prevents their return to the intercellular...
This one-way system allows fluids, solutes, and even pathogens to enter but prevents their return to the intercellular...
3.7K
Intralumenal Vesicles and Multivesicular Bodies
3.6K
Intraluminal vesicles (ILVs) are small vesicles 50-80 nm in diameter formed during the maturation of early endosomes. A specialized endosome containing numerous ILVs is called a multivesicular body (MVB). ILVs contain internalized molecules such as antigens, nucleic acids, proteins, and metabolites. Some of these molecules are released from the MVBs inside exosomes and are transported to other cells. Other MVBs contain molecules that are retained in the ILVs and are later degraded within the...
3.6K


